The legal architecture of the United States’ recent trade offensive has shifted, but for the American corporate landscape, the dust has yet to settle. While a landmark judicial intervention recently dismantled the primary mechanism for country-specific levies, the systemic shocks to global commerce remain embedded in the balance sheets of the nation’s largest firms.
One year after the administration declared a “liberation day” of sweeping import duties, the economy is navigating a paradoxical state: Trump tariffs fall, but trade war impacts linger. The transition from targeted “reciprocal” tariffs to a broader global levy has forced a fundamental cultural shift in how U.S. Companies manage their risk, moving away from “just-in-time” efficiency toward a more expensive, but stable, diversification of supply chains.
This volatility has not been felt equally. While retail giants and pharmaceutical firms have leveraged their scale to negotiate exemptions or absorb costs, smaller enterprises and heavy industries like automotive manufacturing have faced billions in additional overhead. According to Venky Ramesh, a supply chain expert with AlixPartners, roughly 80% to 85% of these costs were absorbed domestically, leaving corporations to either erode their own margins or pass the burden onto the American consumer.
The Legal Pivot: From IEEPA to the Trade Act
The current trade environment is the result of a rapid-fire sequence of executive actions and judicial corrections. On April 2, 2025, the administration initiated broad country-by-country tariffs and a 10% baseline levy. However, the legal foundation for these moves was challenged in the highest court.
On February 20, 2026, the Supreme Court ruled that the reciprocal tariffs imposed under the International Emergency Economic Powers Act (IEEPA) of 1977 were unconstitutional. The ruling was intended to provide relief, but the reprieve was short-lived. Within hours, the administration pivoted, announcing a new 10% global tariff rate under Section 122 of the Trade Act of 1974. This rate was subsequently increased to 15%.
While the IEEPA-based duties fell, other protections remain. Tariffs imposed under Section 232 of the Trade Expansion Act of 1962—designed to protect national security—continue to impact critical imports of aluminum, semiconductors and steel.
| Date | Action | Legal Mechanism |
|---|---|---|
| April 2, 2025 | “Liberation Day” tariffs announced | IEEPA |
| Feb 20, 2026 | Supreme Court strikes down reciprocal tariffs | Judicial Ruling |
| Feb 20, 2026 | Global tariff (10% then 15%) implemented | Trade Act of 1974 |
| Ongoing | Steel and Aluminum duties remain | Section 232 |
Retail and the Divide of Scale
The retail sector serves as a stark example of how market power determines survival during a trade war. Mega-retailers like Walmart, possessing diverse revenue streams and immense negotiating leverage, have remained relatively stable. In contrast, smaller retailers lacking the capital to pivot their sourcing overnight have struggled to survive.
Many firms have adopted a “nimble” strategy to mitigate risk. For instance, Home Depot’s CFO, Richard McPhail, noted that the company is pursuing a goal of limiting any single non-U.S. Country to 10% of its total purchases, with more than half of its inventory already sourced domestically.
However, these structural changes have come at a cost to the shopper. Major brands including Best Buy and Macy’s have raised prices on select items to offset the import levies. Even as some apparel companies saw a temporary boon from the Supreme Court’s ruling on East Asian supply chains, uncertainty remains high. Abercrombie & Fitch, for example, explicitly integrated a 15% tariff assumption into its financial outlook in March, while others, such as Gap and American Eagle Outfitters, have been more cautious about factoring the latest legal changes into their 2026 guidance.
The Industrial Toll: Autos and Consumer Goods
The automotive industry has borne some of the heaviest burdens, with both foreign and domestic manufacturers facing billions in losses. Toyota forecast a 1.4 trillion yen (approximately $9.5 billion) impact from U.S. Tariffs during its fiscal year. Detroit’s “Large Three”—General Motors, Ford, and Stellantis—reported a combined cost of $6 billion last year.
There has been some relief through “de-stacking,” a policy aimed at preventing overlapping duties on both individual parts and completed vehicles. GM CFO Paul Jacobson stated that the company’s 2025 tariff costs were $3.1 billion, which was lower than the previous estimate of $3.5 billion to $4.5 billion.
Consumer packaged goods (CPG) companies have faced a different challenge. Unlike retailers, CPG firms often rely on raw commodities—such as aluminum for cans or pulp for paper products—that cannot be easily sourced from alternative countries. This has led to direct hits to earnings per share (EPS). Procter & Gamble raised prices on 25% of its products following a $1 billion annual tariff impact, while beer maker Constellation Brands estimated a $20 million hit to its 2026 earnings due to aluminum costs.
The Pharmaceutical Quid Pro Quo
The pharmaceutical industry has largely avoided the worst of the trade war by engaging in a series of strategic agreements. Under a “most favored nation” policy, more than a dozen major drugmakers—including Pfizer, Eli Lilly, and Merck—agreed to lower prices for medicines in exchange for a three-year exemption from pharmaceutical tariffs.
This arrangement required companies to commit to significant domestic investments. Johnson & Johnson announced plans to spend more than $55 billion to build four plants in the U.S., while AbbVie committed over $10 billion to domestic manufacturing and capabilities over the next decade.
For those that did not strike deals, the consequences were severe. The administration imposed 100% tariffs on branded drugs from non-compliant makers, although pathways for exemptions exist for companies that commit to onshoring their production over a four-year window.
Disclaimer: This article is provided for informational purposes only and does not constitute financial, legal, or investment advice.
As the U.S. Enters the second year of this trade regime, the focus has shifted from immediate crisis management to long-term structural resilience. The primary checkpoint for the business community will be the upcoming quarterly earnings reports, where executives will be forced to quantify the impact of the 15% global tariff and disclose any potential refunds stemming from the defunct IEEPA duties.
We invite you to share your thoughts on how these trade shifts are affecting your industry in the comments below.
